2021
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
DRDO
|
|
|
ICMR
|
|
|
Bharat Biotech
|
|
|
Cipla
|
Detailed explanation-1: -Union Minister Dr Jitendra Singh lauds the role of Department of Biotechnology (DBT) for supporting the development of world’s first Intranasal vaccine for COVID by Bharat Biotech International Limited (BBIL)
Detailed explanation-2: -What is Bharat Biotech’s Nasal Vaccine Incovacc? Bharat Biotech Incovacc is a “recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.” It stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses, it says.
Detailed explanation-3: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Detailed explanation-4: -BBV154 - A novel adenovirus vectored, intranasal vaccine for COVID-19.
Detailed explanation-5: -BBV154 COVID Vaccine is the first intranasal vaccine approved by DCGI for primary immunization against COVID-19 in the 18+ age group for restricted use in emergency situation being developed in the country under Mission COVID Suraksha and adds to our repertoire of COVID-19 vaccine.